The future of CBD: Is the hemp market hurtling towards a crash?

Cannabidiol (CBD) may be entering mainstream, but Rabobank analysts argue that legal ambiguities and underregulation are the key deterrents for entrants to this new market

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

06 Dec 2019 --- Following the 2018 Farm Bill’s removal of hemp from the definition of marijuana in the Controlled Substances Act, industry has seen a boom in cannabidiol... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Dec 2019 --- US-based beverage brand mood33 has launched a line of hemp-infused herbal teas that contain organic, US-grown, full-spectrum hemp extract, premium botanicals and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Nov 2019 --- Canapure, Symrise’s new active cannabidiol (CBD) ingredient is the latest addition to the company’s product portfolio of approved ingredients. According... Read More

FormattedPicture

REGULATORY NEWS

26 Nov 2019 --- Amid the industry buzz around cannabidiol (CBD), the US Food and Drug Administration (FDA) has sent a firm reminder on the compound’s non-legal status. The... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

25 Nov 2019 --- Cannabidiol (CBD) obtained by “synthetic means” is now excluded from the US Controlled Substance Act (CSA) regulatory controls, as long as it contains... Read More

trans